Sheaff Brock Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-37,052
Closed -$284K 490
2019
Q2
$284K Hold
37,052
0.03% 341
2019
Q1
$195K Hold
37,052
0.02% 437
2018
Q4
$242K Hold
37,052
0.04% 357
2018
Q3
$638K Hold
37,052
0.06% 227
2018
Q2
$517K Hold
37,052
0.05% 251
2018
Q1
$568K Hold
37,052
0.06% 231
2017
Q4
$427K Sell
37,052
-3,400
-8% -$50.6K 0.06% 287
2017
Q3
$769K Buy
40,452
+6,210
+18% +$128K 0.1% 197
2017
Q2
$825K Sell
34,242
-100
-0.3% -$2.19K 0.11% 195
2017
Q1
$681K Sell
34,342
-3,881
-10% -$86.6K 0.09% 227
2016
Q4
$921K Buy
38,223
+494
+1% +$13.8K 0.12% 175
2016
Q3
$1.05M Sell
37,729
-4,036
-10% -$107K 0.14% 146
2016
Q2
$1.02M Buy
41,765
+3,027
+8% +$85.9K 0.13% 162
2016
Q1
$1.3M Sell
38,738
-2,209
-5% -$69.5K 0.16% 132
2015
Q4
$1.22M Buy
+40,947
New +$1.38M 0.14% 160

Other funds holding PGEN

Sheaff Brock Investment Advisors's PGEN Position: Q3 2019 in Review

Sheaff Brock Investment Advisors sold out of Precigen (PGEN) in Q3 2019, closing a stake of 37,052 shares — an estimated $284K sold.

Sheaff Brock Investment Advisors first reported a position in PGEN in Q4 2015 and held it in 15 quarters. The position peaked at $1.3M in Q1 2016. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Sheaff Brock Investment Advisors reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 37,052 Precigen shares in Q3 2019, an estimated $284K.
  • Sheaff Brock Investment Advisors first reported a position in Precigen in Q4 2015 and held it in 15 quarters.
  • Sheaff Brock Investment Advisors's Precigen position peaked at $1.3M in Q1 2016.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.